Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kenvue (KVUE) Cash & Equivalents (2022 - 2025)

Kenvue (KVUE) has disclosed Cash & Equivalents for 4 consecutive years, with $79.0 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 92.62% to $79.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $79.0 million through Dec 2025, down 92.62% year-over-year, with the annual reading at $79.0 million for FY2025, 92.62% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $79.0 million at Kenvue, down from $145.0 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $9.4 billion in Q2 2023, with the low at $79.0 million in Q4 2025.
  • Average Cash & Equivalents over 4 years is $1.6 billion, with a median of $1.1 billion recorded in 2023.
  • The sharpest move saw Cash & Equivalents soared 46.9% in 2023, then crashed 92.62% in 2025.
  • Over 4 years, Cash & Equivalents stood at $838.0 million in 2022, then soared by 64.92% to $1.4 billion in 2023, then dropped by 22.58% to $1.1 billion in 2024, then plummeted by 92.62% to $79.0 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $79.0 million, $145.0 million, and $1.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.